General Updates

July 16, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Fort Bandra Kurla Complex Mumbai - 400 001 Bandra (E) Mumbai - 400 051 Scrip Code: 530019 Trading Symbol: JUBLPHARMA Sub: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") Dear Sir/Madam, Pursuant to the provisions of Regulation 30 of the Listing Regulations, we wish to inform you that the members of the Nomination, Remuneration and Compensation Committee of the Company vide its circular resolution passed today, i.e. on Thursday, July 16, 2026, approved the Grant of 2,07,003 Stock Options/ Restricted Stock Units (RSUs) / Performance Stock Units (PSUs) to the eligible employees under the Jubilant Pharmova Employees Stock Option Plan 2018. Details pursuant to Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are provided in Annexure attached. Date and time for approval – July 16, 2026; 06:11 P.M. You are requested to kindly take the same on record. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary Annexure Disclosure of information pursuant to Regulation 30 of the Listing Regulations read with SEBI Master Circular dated January 30, 2026: 1 Brief details of options granted Grant of 2,07,003 Options/ RSUs/ PSUs to the eligible employee as determined by the Nomination, Remuneration and Compensation Committee 2 Whether the scheme is in terms of Yes SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 3 Total number of shares covered by 2,07,003 Equity Shares of face value Re. 1 each. these options 4 Pricing Formula (Exercise Price) For 1,81,570 RSU/PSU, the Exercise Price is Re. 1 each i.e. face value per equity share of the Company For 25,433 Stock Options, the Exercise Price is Rs. 974.45 each 5 Options Vested (Vesting Schedule) Subject to fulfilment of pre-vesting conditions, RSUs/PSUs/Stock Options will vest as under: Vesting Criteria of 23,102 RSU’s of Re. 1: 3 years from the date of grant based on performance Vesting Criteria of 25,433 Stock Units at Rs. 974.45 each: At the end of: 1st Year: 20% 2nd Year : 30% 5th Year : 50% Vesting Criteria of 1,58,468 PSUs of Re. 1: Shall vest on April 01, 2029 6 Time within which option may be 1,81,570 Stock Options/ RSUs / PSUs shall be exercised (Exercised Period) exercisable within a maximum period of 1 (one) year from the date of vesting of RSUs/PSUs subject to the terms of Jubilant Pharmova Employees Stock Option Plan 2018. 25,433 Stock Options shall be exercisable within a maximum period of 8 (eight) years from the date of grant of Options, subject to the terms of Jubilant Pharmova Employees Stock Option Plan 2018 7 Brief details of significant terms Vesting of Options is subject to a minimum Vesting period of 1 (one) year and maximum vesting period of 5 (five) years from the date of grant as per Jubilant Pharmova Employees Stock Option Plan 2018. Note: The requirements prescribed under sub-clauses (g) to (k), (m) & (n) of Clause 10 of Para B of Annexure I of SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are not applicable.